Forget buy-to-let: I think these 2 FTSE 100 property shares can help you make a million

These two property stocks could offer the potential to outperform the FTSE 100 (INDEXFTSE:UKX), as well as buy-to-let, Peter Stephens believes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While investing in property through a buy-to-let has been seen as a worthwhile move for many investors in the past, changes to taxation and regulations could mean buying FTSE 100 property stocks is now a better idea.

When purchased through a Stocks and Shares ISA, for example, there’s no tax to pay on income or capital growth. And with a number of FTSE 100 property stocks currently providing wide margins of safety, they may offer better value for money than buy-to-let investments.

With that in mind, here are two large-cap stocks that could increase your chances of making a million compared to undertaking a buy-to-let.

Berkeley Group

Housebuilder Berkeley (LSE: BKG) released results for the 2019 financial year on Wednesday. They showed its pre-tax profit was at the top end of guidance, hitting £775.2m. This reflected resilient trading during the year, and allowed the company to increase its net cash position to £975m.

During the 12 months, Berkeley added 14 new sites to its land bank. Its Net Promoter Score of 73.5 is also on a par with a variety of highly-respected consumer brands.

Looking ahead however, the company expects its pre-tax profit for the 2020 financial year to fall by a third. This, though, is in line with previous guidance, and reflects a somewhat challenging operating environment.

But with the company’s shares trading on a price-to-earnings (P/E) ratio of around 11, it seems to offer a sufficiently wide margin of safety to merit investment. With a generous shareholder returns plan, it could offer an impressive mix of income and capital growth.

Persimmon

Offering even better value for money than Berkeley is fellow housebuilder Persimmon (LSE: PSN). It currently trades on a P/E ratio of just 7. This suggests investors are anticipating a sharp decline in its financial performance, which could present a buying opportunity for long-term investors.

Although there are possible risks facing the UK property market, such as a weaker economic performance due to Brexit and an end of the Help to Buy scheme, Persimmon’s financial prospects appear to be encouraging.

In the current year, for example, it’s forecast to deliver a rise in net profit of 3%. And with recent updates from the company suggesting demand for new homes remains high, it could enjoy robust operating conditions over the coming years.

With the company having a generous shareholder return plan, it’s expected to yield around 12% in the current year. Since it has a net cash position, as well as an improving financial outlook, its dividend payments may be more affordable and sustainable over the long run than many investors realise.

As such, it could be a worthwhile purchase for value and income investors, appearing to offer a significantly greater chance of making a million than undertaking a buy-to-let investment.

Peter Stephens owns shares of Berkeley Group Holdings and Persimmon. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »